Amb motiu del tancament d'estiu, la validació de documents es reprendrà a partir del 28 d'agost de 2026. Disculpeu les molèsties.
Con motivo del cierre de verano, la validación de documentos se reanudará a partir del 28 de agosto de 2026. Disculpad las molestias
Due to the summer closure, document validation will resume starting August 28, 2026. We apologize for any inconvenience.

Document type

Article

Version

Accepted version

Publication date

All rights reserved

Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/220243

Mesoporous Silica particles are phagocytosed by microglia and induce a mild inflammatory response in vitro.

Journal Title

Director/Tutor

Journal ISSN

Volume Title

Abstract

Aim: Mesoporous silica particles (MSPs) are broadly used drug delivery carriers. In this study, the authors analyzed the responses to MSPs of astrocytes and microglia, the two main cellular players in neuroinflammation. Materials & methods: Primary murine cortical mixed glial cultures were treated with rhodamine B-labeled MSPs. Results: MSPs are avidly internalized by microglial cells and remain inside the cells for at least 14 days. Despite this, MSPs do not affect glial cell viability or morphology, basal metabolic activity or oxidative stress. MSPs also do not affect mRNA levels of key proinflammatory genes; however, in combination with lipopolysaccharide, they significantly increase extracellular IL-1β levels. Conclusion: These results suggest that MSPs could be novel tools for specific drug delivery to microglial cells.

Citation

Citation

SALA JARQUE, Julia, et al. Mesoporous Silica particles are phagocytosed by microglia and induce a mild inflammatory response in vitro. Nanomedicine. 2022. Vol. 17, num. 15, pags. 1077-1094. ISSN 1743-5889. [consulted: 12 of August of 2026]. Available at: https://hdl.handle.net/2445/220243

Export metadata

JSON - METS

Share record